The role of radiotherapy in the management of progressive glioblastoma: A systematic review and evidence-based clinical practice guideline

Journal of Neuro-Oncology

Volumn 118, Issue 3, 2014, Pages 489-499

  Ryu, Samuel ^a   Buatti, John M ^b   Morris, Ann ^b   Kalkanis, Steven N ^c   Ryken, Timothy Charles ^d   Olson, Jeffrey J ^e  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult; Chemotherapy; Glioblastoma; Progressive; Radiation therapy; Radiosurgery; Recurrent

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CASE CONTROL STUDY; CHEMORADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; FRACTIONATED STEREOTACTIC RADIOSURGERY; GLIOBLASTOMA; HUMAN; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOSURGERY; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; RETROSPECTIVE STUDY; REVIEW; STEREOTACTIC RADIOSURGERY; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ADULT; BRAIN NEOPLASMS; CRANIAL IRRADIATION; EVIDENCE-BASED MEDICINE; GLIOBLASTOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; TREATMENT OUTCOME;

EID: 84903815930     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1337-6     Document Type: Review

References (43)

1. Darefsky AS, King JT Jr, Dubrow R (2012) Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries. Cancer 118(8):2163-2172
2. Koshy M, Villano JL, Dolecek TA et al (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107(1):207-212
3. Easaw JC, Mason WP, Perry J et al (2011) Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme. Curr Oncol 18(3):e126-e136
4. Olson JJ, Fadul CE, Brat DJ, Mukundan S, Ryken TC (2009) Management of newly diagnosed glioblastoma: guidelines development, value and application. J Neurooncol 93(1):1-23
5. Olson JJ, Ryken T (2008) Guidelines for the treatment of newly diagnosed glioblastoma: introduction. J Neurooncol 89(3):255-258
6. Prados M, Cloughesy T, Samant M et al (2011) Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol 13(1):143-151
7. Friedman HS, Prados MD, Wen PY et al (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27(28):4733-4740
8. Dirks P, Bernstein M, Muller PJ, Tucker WS (1993) The value of reoperation for recurrent glioblastoma. Can J Surg 36(3):271-275 (Pubitemid 23248140)
9. Guyotat J, Signorelli F, Frappaz D, Madarassy G, Ricci AC, Bret P (2000) Is reoperation for recurrence of glioblastoma justified? Oncol Rep 7(4):899-904
10. Pannullo SC, Fraser JF, Moliterno J, Cobb W, Stieg PE (2011) Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease. J Neurooncol 103(1):1-17
11. Nieder C, Astner ST, Mehta MP, Grosu AL, Molls M (2008) Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma. Am J Clin Oncol 31(3):300-305
12. Souhami L, Seiferheld W, Brachman D et al (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60(3):853-860 (Pubitemid 39311766)
13. Combs SE, Thilmann C, Edler L, Debus J, Schulz-Ertner D (2005) Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol 23(34):8863-8869 (Pubitemid 46211533)
14. Patel M, Siddiqui F, Jin JY et al (2009) Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol 92(2):185-191
15. Hudes RS, Corn BW, Werner-Wasik M et al (1999) A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 43(2):293-298 (Pubitemid 29091467)
16. Minniti G, Armosini V, Salvati M et al (2011) Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma. J Neurooncol 103(3):683-691
17. Schwer AL, Damek DM, Kavanagh BD et al (2008) A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 70(4):993-1001 (Pubitemid 351296121)
18. Shepherd SF, Laing RW, Cosgrove VP et al (1997) Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 37(2):393-398 (Pubitemid 27138724)
19. Grosu AL, Weber WA, Franz M et al (2005) Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63(2):511-519 (Pubitemid 41317169)
20. Gutin PH, Iwamoto FM, Beal K et al (2009) Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 75(1):156-163
21. Maranzano E, Anselmo P, Casale M et al (2011) Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial. Tumori 97(1):56-61
22. Elliott RE, Parker EC, Rush SC et al (2011) Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. World Neurosurg 76(1-2):128-140; discussion 161-122
23. Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD (1997) Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41(4):776-783; discussion 783-775
24. Combs SE, Bischof M, Welzel T et al (2008) Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol 89(2):205-210
25. Lederman G, Wronski M, Arbit E et al (2000) Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 23(2):155-159
26. Schwer AL, Kavanagh BD, McCammon R et al (2009) Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 73(5):1352-1357
27. Torcuator R, Thind R, Patel M et al (2010) The role of salvage reirradiation for malignant gliomas that progress on bevacizumab. J Neurooncol 97(3):401-407
28. Prados M, Cloughesy T, Samant M et al (2011) Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro-Oncology 13(1):143-151
29. Park KJ, Kano H, Iyer A et al (2012) Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study. J Neurooncol 107(2):323-333
30. Cuneo KC, Vredenburgh JJ, Sampson JH et al (2012) Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 82(5):2018-2024
31. Nieder C, Nestle U, Ketter R et al (1999) Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme. Radiat Oncol Investig 7(1):36-41 (Pubitemid 29078863)
32. Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB (1999) Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 45(5):1133-1141
33. Combs SE, Gutwein S, Thilmann C, Huber P, Debus J, Schulz-Ertner D (2005) Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. J Neurooncol 74(2):167-171 (Pubitemid 41478913)
34. Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R (2009) Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 185(4):235-240
35. Fogh SE, Andrews DW, Glass J et al (2010) Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 28(18):3048-3053
36. Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D (2005) Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Cancer 104(10):2168-2173 (Pubitemid 41579963)
37. Shrieve DC, Alexander E, Wen PY et al (1995) Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36(2):275-282; discussion 282-274
38. Hsieh PC, Chandler JP, Bhangoo S et al (2005) Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 57(4):684-692; discussion 684-692
39. Mahajan A, McCutcheon IE, Suki D et al (2005) Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme. J Neurosurg 103(2):210-217 (Pubitemid 43193894)
40. Hall WA, Djalilian HR, Sperduto PW et al (1995) Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13(7):1642-1648
41. Brazil L, Thomas R, Laing R et al (1997) Verbally administered Barthel Index as functional assessment in brain tumour patients. J Neurooncol 34(2):187-192 (Pubitemid 27271725)
42. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G (2007) Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol 81(3):287-294 (Pubitemid 46165333)
43. Neider C, Nestle U, Niewald M, Walter K, Schnabel K (1999) Hyperfractionated reirradiation for malignant glioma. Front Radiat Ther Oncol 33:150-157